Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 374

1.

Multiple sclerosis and cannabis: a cognitive and psychiatric study.

Ghaffar O, Feinstein A.

Neurology. 2008 Jul 15;71(3):164-9. doi: 10.1212/01.wnl.0000304046.23960.25. Epub 2008 Feb 13.

PMID:
18272863
2.

Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis.

Krupp LB, Sliwinski M, Masur DM, Friedberg F, Coyle PK.

Arch Neurol. 1994 Jul;51(7):705-10.

PMID:
8018045
3.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
4.

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.

Benedict RH, Duquin JA, Jurgensen S, Rudick RA, Feitcher J, Munschauer FE, Panzara MA, Weinstock-Guttman B.

Mult Scler. 2008 Aug;14(7):940-6. doi: 10.1177/1352458508090923. Epub 2008 Jun 23.

PMID:
18573822
5.

Effects of cannabis on cognitive function in patients with multiple sclerosis.

Honarmand K, Tierney MC, O'Connor P, Feinstein A.

Neurology. 2011 Mar 29;76(13):1153-60. doi: 10.1212/WNL.0b013e318212ab0c.

6.

Cognition in the early stage of multiple sclerosis.

Schulz D, Kopp B, Kunkel A, Faiss JH.

J Neurol. 2006 Aug;253(8):1002-10. Epub 2006 Apr 11.

PMID:
16609812
7.

Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.

Akbar N, Honarmand K, Kou N, Feinstein A.

J Neurol. 2011 Mar;258(3):373-9. doi: 10.1007/s00415-010-5760-8. Epub 2010 Oct 6.

PMID:
20924594
8.

The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis.

Siepman TA, Janssens AC, de Koning I, Polman CH, Boringa JB, Hintzen RQ.

J Neurol. 2008 Jun;255(6):910-6. doi: 10.1007/s00415-008-0814-x. Epub 2008 May 20.

PMID:
18484237
9.

Cannabis use in Spanish patients with multiple sclerosis: fulfilment of patients' expectations?

Martínez-Rodríguez JE, Munteis E, Carreño M, Blanco Y, Roquer J, Abanades S, Graus F, Saiz A.

J Neurol Sci. 2008 Oct 15;273(1-2):103-7. doi: 10.1016/j.jns.2008.06.037. Epub 2008 Aug 8.

PMID:
18691726
10.

Neuropsychological performance in long-term cannabis users.

Pope HG Jr, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D.

Arch Gen Psychiatry. 2001 Oct;58(10):909-15.

PMID:
11576028
11.

Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.

Bergendal G, Fredrikson S, Almkvist O.

Eur Neurol. 2007;57(4):193-202. Epub 2007 Jan 1.

PMID:
17272938
12.

Multiple sclerosis and cannabis: a cognitive and psychiatric study.

Messinis L, Papathanasopoulos P.

Neurology. 2009 Jan 6;72(1):100-1; author reply 101. doi: 10.1212/01.wnl.0000339406.02332.79. No abstract available.

PMID:
19122042
13.

Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.

Aragona M, Onesti E, Tomassini V, Conte A, Gupta S, Gilio F, Pantano P, Pozzilli C, Inghilleri M.

Clin Neuropharmacol. 2009 Jan-Feb;32(1):41-7. doi: 10.1097/WNF.0B013E3181633497.

PMID:
18978501
14.

Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients.

Benedict RH, Munschauer F, Zarevics P, Erlanger D, Rowe V, Feaster T, Carpenter RL.

J Neurol. 2008 Jun;255(6):848-52. doi: 10.1007/s00415-008-0760-7. Epub 2008 May 16.

PMID:
18481035
15.

Cognitive functioning in euthymic bipolar I and bipolar II patients.

Dittmann S, Hennig-Fast K, Gerber S, Seemüller F, Riedel M, Emanuel Severus W, Langosch J, Engel RR, Möller HJ, Grunze HC.

Bipolar Disord. 2008 Dec;10(8):877-87. doi: 10.1111/j.1399-5618.2008.00640.x.

PMID:
19594503
16.

Attention related performance in two cognitively different subgroups of patients with multiple sclerosis.

Kujala P, Portin R, Revonsuo A, Ruutiainen J.

J Neurol Neurosurg Psychiatry. 1995 Jul;59(1):77-82.

17.

Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study.

de Sola S, Tarancón T, Peña-Casanova J, Espadaler JM, Langohr K, Poudevida S, Farré M, Verdejo-García A, de la Torre R.

Psychopharmacology (Berl). 2008 Oct;200(3):425-37. doi: 10.1007/s00213-008-1217-5. Epub 2008 Jun 26.

PMID:
18581098
18.

Cannabis use, cognitive performance and mood in a sample of workers.

Wadsworth EJ, Moss SC, Simpson SA, Smith AP.

J Psychopharmacol. 2006 Jan;20(1):14-23. Epub 2005 Oct 4.

PMID:
16204329
19.

[BCcogSEP: a French test battery evaluating cognitive functions in multiple sclerosis].

Dujardin K, Sockeel P, Cabaret M, De Sèze J, Vermersch P.

Rev Neurol (Paris). 2004 Jan;160(1):51-62. French.

PMID:
14978394
20.

The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial.

Morrow SA, Kaushik T, Zarevics P, Erlanger D, Bear MF, Munschauer FE, Benedict RH.

J Neurol. 2009 Jul;256(7):1095-102. doi: 10.1007/s00415-009-5074-x. Epub 2009 Mar 5.

PMID:
19263186

Supplemental Content

Support Center